Compare SQM & PODD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SQM | PODD |
|---|---|---|
| Founded | 1968 | 2000 |
| Country | Chile | United States |
| Employees | N/A | N/A |
| Industry | Mining & Quarrying of Nonmetallic Minerals (No Fuels) | Medical/Dental Instruments |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 17.6B | 17.0B |
| IPO Year | 1997 | 2007 |
| Metric | SQM | PODD |
|---|---|---|
| Price | $77.12 | $230.09 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 10 | 20 |
| Target Price | $67.85 | ★ $357.65 |
| AVG Volume (30 Days) | 965.5K | ★ 1.0M |
| Earning Date | 01-01-0001 | 05-20-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 3.48 |
| Revenue | N/A | ★ $2,708,100,000.00 |
| Revenue This Year | N/A | $24.33 |
| Revenue Next Year | $19.43 | $19.33 |
| P/E Ratio | ★ $39.64 | $66.59 |
| Revenue Growth | N/A | ★ 30.73 |
| 52 Week Low | $29.36 | $216.49 |
| 52 Week High | $86.13 | $354.88 |
| Indicator | SQM | PODD |
|---|---|---|
| Relative Strength Index (RSI) | 54.81 | 38.56 |
| Support Level | $75.20 | N/A |
| Resistance Level | $81.67 | $299.75 |
| Average True Range (ATR) | 2.91 | 7.52 |
| MACD | 0.41 | -0.71 |
| Stochastic Oscillator | 86.11 | 37.24 |
Sociedad Quimica y Minera de Chile is a Chilean commodities producer with significant operations in lithium (primarily used in batteries for electric vehicles and energy storage systems), specialty and standard potassium fertilizers, iodine (primarily used in X-ray contrast media), and solar salts. The company extracts these materials through its high-quality salt brine deposits and caliche ore. SQM also sells lithium concentrate from a joint venture hard rock lithium project in Australia and expanding its lithium refining assets in China.
Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the US Food and Drug Administration in 2005, approximately 500,000 insulin-dependent diabetic patients are using it worldwide.